US Stock Movement: Iovance surged on October 9 with revenue increase and Amtagvi
Bitget异动解读2026/10/09 14:30Iovance October 9th Surge Analysis
Keywords: Revenue upgrade, Amtagvi
1. On September 29, the company raised its full-year 2026 total revenue guidance from $350 million–$370 million to $410 million–$420 million. The midpoint increased by $55 million, or about 15%, and exceeds the consensus estimate of $402.8 million, driving up revenue expectations.
2. In the second quarter of 2026, the company achieved record product revenue of $99.3 million. Demand in the US market for Amtagvilifileucel and Proleukin was strong. The authorized treatment center network has expanded to about 100 centers, with plans to reach at least 110 by the end of 2026, providing visibility for third and fourth quarter revenues.
(Disclaimer: This content is generated by AI technology summarizing public information and is for reference only; it does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Societe Generale lowers Tesla's target price to $266
Société Générale has lowered the Tesla (TSLA.US) target price from $268 to $266.
US Stock Movement | Pony.ai (PONY.US) rises over 5%, seventh-generation Robotaxi to be introduced in London, UK
According to Zhihu Finance App, PONY.AI (PONY.US) rose over 5% on Friday, closing at $6.07. The news comes as, on October 8, autonomous driving company PONY.AI and global mobility platform Uber announced that they are moving forward with the introduction of PONY.AI's seventh-generation Robotaxi in London, UK, with road testing expected to officially begin in the coming weeks. London will become another key city in the companies' strategy for large-scale Robotaxi deployment in Europe.
Crypto prices
More
